ETF Evaluator:
State Street®HlthCrSelSectSPDR®ETF ()
Follow This ETF
(as of Aug 26)
Best Performing in Health Over the Last Year
| 129.4% | Virtus LifeSci Biotech Clinical Trls ETF (BBC) |
| 94.1% | ALPS Medical Breakthroughs ETF (SBIO) |
| 88.4% | F/m Emerald Life Sciences Innovation ETF (LFSC) |
| 72.5% | State Street® SPDR® S&P® Biotech ETF (XBI) |
| 65.8% | State Street® SPDR® S&P® PhrmctlsETF (XPH) |
Risk
Index
Risk
Index
ETF Details
State Street®HlthCrSelSectSPDR®ETF Overview
State Street®HlthCrSelSectSPDR®ETF (XLV) is a passively managed Sector Equity Health exchange-traded fund (ETF). State Street Investment Management launched the ETF in 1998.
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index.
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
About State Street®HlthCrSelSectSPDR®ETF (XLV)
There are 3 members of the management team with an average tenure of 4.50 years: Emiliano Rabinovich (2026), Juan Acevedo (2025) and Karl Schneider (2015). Management tenure is more important for actively managed ETFs than passive index ETFs.
The ETF has 2 primary benchmarks: S&P 500 (TR) (1970) index with a weighting of 100% and S&P Health Care Select Sector TR USD index with a weighting of 100%. State Street®HlthCrSelSectSPDR®ETF has 63 securities in its portfolio. The top 10 holdings constitute 60.9% of the ETF’s assets. The ETF meets the SEC requirement of being classified as a nondiversified fund. The ETF is not considered to have an ESG focus with its investment selection and management.
State Street®HlthCrSelSectSPDR®ETF is part of the Equity global asset class and is within the Sector Equity ETF group. State Street®HlthCrSelSectSPDR®ETF has 0.0% of its portfolio invested in foreign issues. The overall assets allocated to domestic stock is 99.9% There is 0.0% allocated to foreign stock, and 0.0% is allocated to preferred stocks. The bond allocation as a percentage of total assets is 0.0% (0.0% domestic bond, 0.0% foreign bond and 0.0% convertible bond). State Street®HlthCrSelSectSPDR®ETF has 0.1% of the portfolio in cash.
Assets Under Management
The fund has $41 billion in total assets, which is above the $1 billion average for the Health category. Normally, lower assets under management translates to higher average expense ratios, and greater total assets are desired. However, for some investment categories, such as small-cap investing, it may be difficult for the manager to fully employ the desired active strategy if assets grow too large or too quickly.
XLV Performance and Fees
The expense ratio measures how much of a fund’s assets are used for administrative expenses and operating expenses, including adviser fees and fees for the transfer agent and custodial services. The State Street®HlthCrSelSectSPDR®ETF expense ratio is low compared to funds in the Health category. State Street®HlthCrSelSectSPDR®ETF has an expense ratio of 0.08%, which is 85% lower than its category average, making the fund expense ratio grade a A. While it is difficult to predict returns, it is known that high annual expense ratios reduce your rate of return, and excessive fees are difficult to overcome. Active management normally comes with higher expense ratios than passive index management. Certain investment categories such as small company and foreign also normally have higher expense ratios. It is best to compare fund expense ratios against the category averages for meaningful assessments.
High portfolio turnover can translate to higher expenses and lower aftertax returns. State Street®HlthCrSelSectSPDR®ETF has a portfolio turnover rate of 2%, which indicates that it holds its assets around / 0.5 years. By way of comparison, the average portfolio turnover is 45% for the Health category.
Recently, in the month of July 2026, State Street®HlthCrSelSectSPDR®ETF returned 2.4%, which earned it a grade of A, as the Health category had an average return of -0.1%. The letter grades of A, B, C, D and F are based upon relative rankings within the investment category. A grade of A, for example, would indicate that the return is in the highest 20% for that time period compared to all ETFs in that category.
State Street®HlthCrSelSectSPDR®ETF has a trailing yield of 1.56%, which is above the 1.10% category average.
The fund normally distributes its income quarterly and its capital gains annually.
It’s natural to seek the best-performing investments, but you must consider the relationship between risk and return and the impact of costs and taxes on your realized returns.
State Street®HlthCrSelSectSPDR®ETF Grades
Year to date, the ETF has returned 5.9%, 3.8 percentage points worse than the category, which translates into a grade of D. The fund has returned 26.8% over the past year (grade of D), 8.4% over the past three years (grade of C) and 5.9% per year over the past five years (grade of B) and 9.8% per year over the past 10 years (grade of A).
For more ETF grades, analysis and screening tools to help your investment discovery, join AAII for a $2, full-access trial. Learn more here: https://invest.aaii.com/membership.
Otherwise, for more information about State Street®HlthCrSelSectSPDR®ETF, including its riskiness, submit your email to unlock the rest of the article.
Gain access to exclusive AAII member-only content.
XLV Trailing NAV Total Returns Data as of 7/31/26
| Last Month |
Last Quarter |
Ann'l. 1Yr |
Ann'l. 3Yr |
Ann'l. 5Yr |
Ann'l. 10Yr |
|
| XLV Return (NAV) | 2.4% | 11.9% | 26.8% | 8.4% | 5.9% | 9.8% |
| XLV Return (Price) | 2.5% | 11.8% | 26.8% | 8.4% | 5.9% | 9.8% |
| NAV +/- Price Return | -0.057% | 0.030% | -0.000% | 0.009% | 0.009% | -0.007% |
| Health Avg | -0.1% | 11.2% | 36.9% | 9.9% | 1.6% | 8.7% |
| XLV Grade (NAV) | A | C | D | C | B | A |
| +/- Category (NAV) | 2.5% | 0.6% | -10.1% | -1.5% | 4.3% | 1.1% |
| XLV Tax-Cost Ratio | na | na | 0.6% | 0.6% | 0.6% | 0.6% |
XLV Annual NAV Total ReturnsData as of 7/31/26
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| XLV Return (NAV) | 5.9% | 14.5% | 2.5% | 2.0% | -2.0% | 25.9% | 13.3% | 20.6% | 6.3% | 21.7% | -2.8% |
| XLV Return (Price) | 5.9% | 14.5% | 2.5% | 2.1% | -2.1% | 26.0% | 13.3% | 20.4% | 6.3% | 21.8% | -2.8% |
| NAV +/- Price Ret | -0.001% | -0.001% | -0.011% | 0.037% | 0.022% | 0.004% | 0.001% | -0.9% | -0.2% | 0.3% | -2.5% |
| Health Avg | 9.7% | 21.8% | 0.1% | 2.2% | -16.3% | 4.3% | 30.5% | 25.4% | -1.5% | 26.5% | -10.2% |
| XLV Grade (NAV) | D | D | B | C | A | A | F | D | A | D | B |
| +/- Category | -3.8% | -7.3% | 2.4% | -0.2% | 14.3% | 21.6% | -17.1% | -4.8% | 7.8% | -4.7% | 7.4% |
| Risk Measures | |
| Beta: | 0.51 |
| R-Squared: | 21% |
| Standard Deviation: | 14.1% |
| Category Risk Index: | 0.70 |
| Category Risk Rating: | Low |
| Total Risk Index: | 1.15 |
| Total Risk Rating: | Average |
| Portfolio Characteristics | |
| Yield: | 1.6% |
| Total Assets: | $ 41,750 Mil |
| Share Class Assets: | $ 41,750 Mil |
| Turnover: | 2.0% |
| Expense Ratio: | 0.08% |
| Index Fund: | Yes |
| Index Tracked: | S&P 500 (TR) (1970) |
| Index Weighting: | 100% |
| Leveraged: | No |
| Socially Responsible Fund: | No |
| Capital Gains Distribution Frequency: | Annually |
| Income Distribution Frequency: | Quarterly |
Management Team
| Number of Managers: 3 | |||
| Longest Tenure: 11.5 years | |||
| Average Tenure: 4.5 years | |||
| Managers (Year): Schneider Karl (2015), Acevedo Juan (2025), Rabinovich Emiliano (2026) | |||
Portfolio Composition (as of 7/31/26)
| # of Holdings: | 63 |
| % in Top 10 Holdings: | 60.9% |
| Fund is Non-Diversified: | Yes |
| % in Foreign Issues: | 0.0% |
Portfolio Allocation |
|
| Domestic Stock: | 99.9% |
| Foreign Stock: | 0.0% |
| Preferred Stock: | 0.0% |
| Domestic Bond: | 0.0% |
| Foreign Bond: | 0.0% |
| Convertible Bond: | 0.0% |
| Other: | 0.0% |
| Cash: | 0.1% |
Purchase Information
| Legal Structure: | Open Ended Investment Company |
| Fund Family: | State Street Investment Management |
| Phone Number: | 866-732-8673 |
| Website: | www.spdrs.com |
| Inception Date: | December 16, 1998 |
Expenses and Fees
| Expense Ratio (%): | 0.08% (Rating: Low) |
| Category Average Expense Ratio (%): | 0.52% |